NFSG
VNRX icon

Newbridge Financial Services Group’s VolitionRx Ltd VNRX Stock Holding History

Newbridge Financial Services Group’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-125
Closed -$1.72K – 1339
2023
Q3 		$1.72K Hold
125
– – ﹤0.01% 1093
2023
Q2 		$3.48K Hold
125
– – ﹤0.01% 1067
2023
Q1 		$4.78K Buy
+125
New +$5.23K ﹤0.01% 1082

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAMC
Spectrum Asset Management (California) Newport Beach, California $315M AUM 19.93% 1-Year Est. Return

Newbridge Financial Services Group's VNRX Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of VolitionRx Ltd (VNRX) in Q4 2023, closing a stake of 125 shares — an estimated $1.72K sold.

Newbridge Financial Services Group first reported a position in VNRX in Q1 2023 and held it in 3 quarters. The position peaked at $4.78K in Q1 2023. 28 funds tracked by Wall St. Rank hold VNRX as of Q4 2023.

  • Newbridge Financial Services Group reported no remaining VolitionRx Ltd position as of Q4 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 125 VolitionRx Ltd shares in Q4 2023, an estimated $1.72K.
  • Newbridge Financial Services Group first reported a position in VolitionRx Ltd in Q1 2023 and held it in 3 quarters.
  • Newbridge Financial Services Group's VolitionRx Ltd position peaked at $4.78K in Q1 2023.
  • 28 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.